Frankfurt am Main, Germany

Andreas Lindenschmidt


 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 45(Granted Patents)


Location History:

  • Sulzbach, DE (2011)
  • Frankfurt-am-Main, DE (2012 - 2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Inventor Spotlight: Andreas Lindenschmidt from Frankfurt am Main

Introduction

Andreas Lindenschmidt is a prominent inventor based in Frankfurt am Main, Germany. With a remarkable portfolio of seven patents, he has made significant contributions to the fields of medicinal chemistry and pharmacology. His innovative work has paved the way for new therapeutic approaches to athero-thrombotic diseases.

Latest Patents

Lindenschmidt's latest innovations include two notable patents that showcase his expertise:

1. **Cyclic Peptides, Their Preparation and Their Use as Inhibitors of the Platelet Adhesion**: This invention involves compounds of a specific formula, which are valuable pharmacologically active compounds. These compounds are reversible inhibitors of the interaction between the plasma protein von Willebrand factor (vWF) and the blood platelet receptor glycoprotein Ib-IX-V complex (GPIb). They hold promise for the therapy and prophylaxis of athero-thrombotic diseases.

2. **Regioselective Copper Catalyzed Synthesis of Benzimidazoles and Azabenzimidazoles**: This patent describes a process for the regioselective synthesis of compounds that can be derived from 2-halo-nitroarenes and N-substituted amides. The invention presents a direct copper-catalyzed approach to create a variety of unsymmetrical, multifunctional N-substituted benzimidazoles or azabenzimidazoles.

Career Highlights

Throughout his career, Andreas Lindenschmidt has worked for esteemed companies in the pharmaceutical industry, notably at Sanofi and Sanofi-Aventis. His experience in these organizations has greatly influenced his innovative endeavors and technical expertise.

Collaborations

Lindenschmidt has collaborated with several professionals in the field, including Jorge Alonso and Matthias Urmann. These partnerships have enriched his work and contributed to the successful development of his patents.

Conclusion

Andreas Lindenschmidt exemplifies the spirit of innovation through his impactful inventions and collaborations in the realm of medicinal chemistry. His contributions not only advance scientific knowledge but also hold the potential to significantly improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…